Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
Regeneron(REGN) The Motley Fool·2025-02-04 23:44News of a significant earnings beat propelled Regeneron Pharmaceuticals (REGN 4.53%) to a nearly 5% share price gain on the second trading day of the week. The company posted its fourth-quarter and full-year 2024 results before market open, and investors were clearly impressed by the numbers. Regeneron's price zoomed well higher than the S&P 500 index's trajectory, which was a rise of 0.7% on the day.A crushing bottom-line beatThe quarter saw Regeneron grow its revenue by 10% year over year to just under $3 ...